The MolecuLight i:X® and DX™ point-of-care imaging devices enable detection of elevated bacterial loads and accurate digital wound measurement. They facilitate proactive wound care and inform clinician decision-making in real-time including enabling guided cleaning and debridement. US reimbursement pathway is enabled, along with 80+ peer-reviewed publications.